Institute For Wealth Management, Llc. Abb Vie Inc. Transaction History

Institute For Wealth Management, Llc.

$766 Million
Q1 2024

A detailed history of Institute For Wealth Management, Llc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Institute For Wealth Management, Llc. holds 20,157 shares of ABBV stock, worth $3.46 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

20,157

Previous 20,290 0.66%

Holding current value

$3.46 Million

Previous $3.14 Million 16.73%

% of portfolio

0.48%

Previous 0.52%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $21,256 - $24,219	-133 Reduced 0.66%	20,157 $3.67 Million
Q4 2023 Jan 31, 2024	SELL	$137.6 - $154.97 $46,508 - $52,379	-338 Reduced 1.64%	20,290 $3.14 Million
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $16,565 - $19,176	-124 Reduced 0.6%	20,628 $3.07 Million
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $161,927 - $201,507	-1,222 Reduced 5.56%	20,752 $2.8 Million
Q1 2023 Apr 20, 2023	SELL	$144.61 - $166.54 $69,123 - $79,606	-478 Reduced 2.13%	21,974 $3.5 Million

Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $35,683 - $42,794	-258 Reduced 1.14%	22,452 $3.63 Million
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $14,226 - $16,316	106 Added 0.47%	22,710 $3.05 Million
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $25,734 - $32,717	-187 Reduced 0.82%	22,604 $3.46 Million
Q1 2022 Apr 29, 2022	BUY	$131.98 - $163.75 $64,142 - $79,582	486 Added 2.18%	22,791 $3.7 Million
Q4 2021 Jan 21, 2022	BUY	$107.43 - $135.93 $2,041 - $2,582	19 Added 0.09%	22,305 $3.02 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $36,495 - $41,427	343 Added 1.56%	22,286 $2.4 Million
Q2 2021 Jul 21, 2021	SELL	$105.21 - $117.21 $66,492 - $74,076	-632 Reduced 2.8%	21,943 $2.47 Million
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $66,188 - $72,865	647 Added 2.95%	22,575 $2.44 Million
Q4 2020 Feb 01, 2021	BUY	$80.49 - $108.67 $57,550 - $77,699	715 Added 3.37%	21,928 $2.35 Million
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $75,686 - $88,831	881 Added 4.33%	21,213 $1.86 Million
Q2 2020 Jul 30, 2020	BUY	$73.37 - $98.18 $279,392 - $373,869	3,808 Added 23.05%	20,332 $2 Million
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $29,089 - $44,103	451 Added 2.81%	16,524 $1.26 Million
Q4 2019 Feb 27, 2020	BUY	$72.13 - $90.25 $1.06 Million - $1.32 Million	14,650 Added 1029.52%	16,073 $1.42 Million
Q4 2019 Jan 27, 2020	SELL	$72.13 - $90.25 $869,599 - $1.09 Million	-12,056 Reduced 89.44%	1,423 $1.42 Million
Q3 2019 Oct 28, 2019	SELL	$62.98 - $75.72 $50,572 - $60,803	-803 Reduced 5.62%	13,479 $1.02 Million
Q2 2019 Aug 02, 2019	BUY	$65.7 - $83.98 $30,090 - $38,462	458 Added 3.31%	14,282 $1.04 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $8,408 - $9,896	109 Added 0.79%	13,824 $1.11 Million
Q4 2018 Feb 08, 2019	SELL	$77.85 - $96.01 $29,894 - $36,867	-384 Reduced 2.72%	13,715 $1.26 Million
Q3 2018 Oct 29, 2018	BUY	$88.91 - $98.84 $15,914 - $17,692	179 Added 1.29%	14,099 $1.32 Million
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $23,971 - $28,363	267 Added 1.96%	13,920 $1.29 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $74,252 - $99,430	807 Added 6.28%	13,653 $1.32 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $131,294 - $143,975	-1,466 Reduced 10.24%	12,846 $1.25 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $13,760 - $17,576	-197 Reduced 1.36%	14,312 $1.28 Million
Q2 2017 Aug 14, 2017	BUY	N/A	14,509	14,509 $1.06 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institute For Wealth Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Institute For Wealth Management, Llc. with notifications on news.

Account

Institute For Wealth Management, Llc. Abb Vie Inc. Transaction History